| Symbol | ZURA |
|---|---|
| Name | ZURA BIO LTD |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 4225 EXECUTIVE SQUARE, LA JOLLA, CA 92037 |
| Telephone | 858-247-0520 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001855644 |
| Description | None |
📋 SOMEIT SIDHU (Director) plans to sell 50K shares of ZURA BIO LIMITED (at $5.75 each, total $288K) Filed: Aug 18, 2026 | ID: 008360
Read more📋 SOMEIT SIDHU (Director) plans to sell 27K shares of ZURA BIO LIMITED (at $5.61 each, total $151K) Filed: Aug 17, 2026 | ID: 008288
Read more(10% Negative) ZURA BIO LTD (ZURA) Announces Delay in identified Development Timeline Due to Geopolitical Situation, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment
Read more📋 SOMEIT SIDHU (Director) plans to sell 40K shares of ZURA BIO LIMITED (at $5.51 each, total $221K) Filed: Aug 14, 2026 | ID: 008157
Read more📋 SOMEIT SIDHU (Director) plans to sell 51K shares of ZURA BIO LIMITED (at $5.63 each, total $287K) Filed: Aug 13, 2026 | ID: 008110
Read moreZura Bio Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
Read more(10% Negative) ZURA BIO LTD (ZURA) Announces Delay in identified Development Timeline Due to Geopolitical Situation, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment
Read moreZura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies and Expands Tibulizumab Program
Read moreJarrett Jennifer 🟢 acquired 51.0K shares (1 derivative) of Zura Bio Ltd (ZURA) at $3.62 Transaction Date: Jun 17, 2026 | Filing ID: 000005
Read more